The complications involved in drinking of alcohol and the
number of alcoholics is increasing day by day. However, the number of available
medications to treat alcohol use disorders is very low. Recently a new
treatment was developed by the scientists to lower the alcohol withdrawalcraving symptoms that involves administering low doses of Buprenorphine.
Currently, the incidence of psychiatric problems is
progressin. Considering psychiatric disorders, substance associated disorders,
especially alcohol and stimulants induced disorders have been considered as
progressive problemsAlthough the number of deaths and other problems caused
by drinking of alcohol is raising, however, the number of medications available
to treat alcohol use disorders is very low.
The FDA indicated use of
buprenorphine is for the treatment of pain and opioids withdrawal .Now, we are
administering buprenorphine as a new access for the treatment of severe alcohol
withdrawal craving, because we think and theorize that (our rationale)
biochemistry engaged in opioid dependence is mainly similar to that of alcohol
(both substances increase the level of endorphins and enkephalins). Read more....................
















